ReviewBioscience reports2026

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

Mohan Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.